It was a good conference call. Addressed everything expected.
My thoughts-
Establishment of regional centers is good marketing strategy. Geneva- good choice due to international presence of NGOs. Local manufacturing in Dubais for middle east market and Africa- good choice.
UAE, sales underway over the counter. Efforts made in Bahran, Saudi Arabia, Kurait, Jordan, Lebanon, maybe Egypt, interest from the Kurdish Regional Govt in N. Iraq.
BED test sales on back order, almost all completed and shipped.
Working with Congress Representative Hooley. She delivered 10,000 tests to Kenya government, Ministry of Health.
Company has started more aggressive lobbying on Capital Hill.
Met with Clinton Foundation for possible future joint project together.
China: Answers to questions submitted to SFDA. If no further questions will go to Committee for approval. Facility ready to manufacture there. Sales 30 to 90 days after approval.
Africa: Test found effective in mines. Getting recognition. Hoping to get on govt. tender lists.
India: Trials completed. Application submitted. Preparing for regional office if application is accepted. Govt interested in products.
CDC: Working together with Syphllis rapid test, with Dr. George, Calypte Science Advisor.
US: Seeking new facility. Expect news soon. Combining R&D with Administrative staff. Seeking 2-3 more scientists for U.S. R&D, prepare pilot of products for US markets.
Global regional offices in:
Dubais - serve Middle East and Africa
Geneva - serve Europe for Europe Expansion
India - serve S. Asia
Beijing - Serve East and South East Asia
Portland - Serve U.S. markets, headquarters
Good strategy with presence in key areas.
More aggressive marketing on regional level--regional manufacturing of the product-save considerably on ship cost, less cost to consumer-improves cost competition with other tests.
The product has eighteen months shelf life compared to six months shelf life of competitor. Shelf life important to volume sales.
Expect considerable improvement in the second quarter in respect to first quarter revenue. NICE!
News 
Market Data 
Discover 
